Phase I Pharmacokinetic and Safety Trial of Ledipasvir/Sofosbuvir Fixed Dose Combination in Pregnant Women With Chronic Hepatitis C Virus Infection
Phase of Trial: Phase I
Latest Information Update: 20 Nov 2016
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- 03 Sep 2016 Planned End Date changed from 1 Jul 2018 to 1 Sep 2018.
- 03 Sep 2016 Planned primary completion date changed from 1 Jul 2018 to 1 Sep 2018.
- 03 Sep 2016 Status changed from not yet recruiting to recruiting.